8-K

CME GROUP INC. (CME)

8-K 2024-05-13 For: 2024-05-09
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 13, 2024 (May 9, 2024)

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

Delaware 001-31553 36-4459170
(State or Other Jurisdiction<br> <br>of Incorporation) (Commission<br> <br>File No.) (IRS Employer<br> <br>Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading<br> <br>symbol Name of each exchange<br> <br>on which registered
Class A Common Stock CME Nasdaq

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (

see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its 2024 Annual Meeting of Shareholders on May 9, 2024 (the “Annual Meeting”).

At the close of business on March 11, 2024, the record date of the Annual Meeting, the Company had 360,025,217 shares of Class A and Class B common stock issued and outstanding. The following shares were present at the Annual Meeting, either in person at the virtual shareholder meeting or by proxy.

Class(es) of Common Stock Aggregate No. of<br>Shares % of the Issued and<br>Outstanding
Classes A and B 314,467,507 87.34 %
Class B-1 108 17.28 %
Class B-2 156 19.19 %
Class B-3 186 14.45 %
Class B-4 80 14.04 %

The results of the proposals are as follows:

1. The election of seventeen Equity Directors to serve until 2025 (elected by the Class A and Class B shareholders voting together as a single class):
Name Votes For Against Abstain
--- --- --- --- --- --- ---
Terrence A. Duffy 264,576,518 23,927,907 2,198,870
Kathryn Benesh 287,025,625 3,377,766 299,904
Timothy S. Bitsberger 271,199,149 18,826,377 677,769
Charles P. Carey 250,175,640 38,943,118 1,584,537
Bryan T. Durkin 276,236,227 14,134,156 332,912
Harold Ford Jr. 286,905,347 3,543,234 254,714
Martin J. Gepsman 245,526,452 44,777,087 399,756
Larry G. Gerdes 258,928,745 31,252,047 522,503
Daniel R. Glickman 247,915,795 41,955,656 831,844
Daniel G. Kaye 281,647,502 8,734,716 321,077
Phyllis M. Lockett 186,404,669 103,767,613 531,013
Deborah J. Lucas 286,554,619 3,804,978 343,698
Terry L. Savage 262,369,321 27,634,626 699,348
Rahael Seifu 279,119,772 10,896,682 686,841
William R. Shepard 265,731,090 24,770,177 202,028
Howard J. Siegel 265,983,505 24,482,362 237,428
Dennis A. Suskind 242,126,932 48,090,239 486,124

There were a total of 23,764,212 broker non-votes in this proposal.

2. The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2024 (ratified by the Class A and Class B shareholders voting together as a single class):
Votes For Votes Against Abstentions
--- --- ---
289,766,319 24,482,330 218,858
3. The advisory vote of the compensation of the Company’s named executive officers (by the Class A and Class B shareholders voting together as a single class) was approved:
--- ---
Votes For Votes Against Abstentions
--- --- ---
253,068,323 37,272,265 362,707

There were a total of 23,764,212 broker non-votes in this proposal.

4. The election of Class B Directors:
a. In the election of the three Class B-1 Directors, no quorum was achieved. Therefore, William W. Hobert, Patrick J. Mulchrone and Robert J. Tierney Jr. are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2025 Annual Meeting or their earlier resignation or removal.
--- ---
Name Votes For Votes Against Abstentions
--- --- --- --- --- --- ---
William W. Hobert 97 7 4
Patrick J. Mulchrone 102 3 3
Robert J. Tierney Jr. 101 5 2
a. In the election of the two Class B-2 Directors, no quorum was achieved. Therefore, Michael G. Dennis and Patrick W. Maloney are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2025 Annual Meeting or their earlier resignation or removal.
--- ---
Name Votes For Votes Against Abstentions
--- --- --- --- --- --- ---
Michael G. Dennis 132 16 8
Patrick W. Maloney 142 10 4
b. In the election of one Class B-3 Director, no quorum was achieved. Therefore, Elizabeth A. Cook is a “holdover” under Delaware law and the Company’s bylaws. She will continue to serve until her successor is duly elected at the 2025 Annual Meeting or her earlier resignation or removal.
--- ---
Name Votes For Votes Against Abstentions
--- --- --- --- --- --- ---
Elizabeth A. Cook 157 26 3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CME Group Inc.
Registrant
Date: May 13, 2024 By: /s/ Jonathan Marcus
Name: Jonathan Marcus
Title: Senior Managing Director and General Counsel